Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$40.4 - $59.1 $161,600 - $236,400
-4,000 Reduced 2.25%
174,000 $7.08 Million
Q1 2023

May 09, 2023

BUY
$38.16 - $48.86 $2.98 Million - $3.81 Million
78,000 Added 78.0%
178,000 $8.62 Million
Q4 2022

Feb 13, 2023

SELL
$33.53 - $54.79 $2.11 Million - $3.45 Million
-63,000 Reduced 38.65%
100,000 $3.82 Million
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $2.44 Million - $3.14 Million
58,344 Added 55.75%
163,000 $8.18 Million
Q2 2022

Aug 03, 2022

BUY
$25.6 - $45.23 $1.6 Million - $2.83 Million
62,656 Added 149.18%
104,656 $4.19 Million
Q1 2022

May 12, 2022

SELL
$33.33 - $44.6 $99,990 - $133,800
-3,000 Reduced 6.67%
42,000 $1.57 Million
Q4 2021

Feb 02, 2022

SELL
$35.36 - $41.86 $1.84 Million - $2.18 Million
-52,100 Reduced 53.66%
45,000 $1.79 Million
Q3 2021

Nov 12, 2021

SELL
$37.01 - $44.74 $481,130 - $581,620
-13,000 Reduced 11.81%
97,100 $3.61 Million
Q2 2021

Aug 30, 2021

SELL
$37.95 - $49.37 $4.18 Million - $5.44 Million
-110,100 Reduced 50.0%
110,100 $4.65 Million
Q2 2021

Aug 13, 2021

BUY
$37.95 - $49.37 $4.56 Million - $5.93 Million
120,100 Added 119.98%
220,200 $9.31 Million
Q1 2021

May 10, 2021

BUY
$46.8 - $68.92 $3.28 Million - $4.82 Million
70,000 Added 232.56%
100,100 $4.74 Million
Q3 2020

Nov 16, 2020

BUY
$45.41 - $57.07 $4,541 - $5,707
100 Added 0.33%
30,100 $1.41 Million
Q2 2020

Aug 14, 2020

BUY
$42.56 - $54.98 $1.28 Million - $1.65 Million
30,000 New
30,000 $1.52 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.03B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.